Similar Posts
Another BU researcher catches the bug he is studying/Boston Globe
This week it was Neisseria meningitidis–which can rapidly kill (and spread). The affected grad student diagnosed himself. Last time (2004) several researchers at BU developed tularemia, a less acute illness. The diagnosis took longer, the disease was less likely to spread, but notifying the authorities took 6 months. The problem is that you can’t run…
Are we rats in a cage to the social psychologists?
I have mentioned the psychological operations used to convince people to get vaccinated occasionally before, but I have not discussed the psychological schemes deliberately applied to make people turn on each other. The Naked Emperor has done so. SPI-B was the name of the psychological warfare operation in the UK. It was a subgroup of…
Vaccine Delays: limited info on the problems/Science Insider
From Jon Cohen and Martin Enserink, excerpts: For proprietary reasons, Lurie would not name the delay issues at each manufacturer, but said “one company was just really overoptimistic” in its delivery predictions to HHS. Initially, all of the makers of inactivated vaccine had trouble with the “potency assay” used to ensure that 15 micrograms of…
Johnson & Johnson suffers another setback as FDA tells Md. vaccine maker to suspend production/ WaPo
From the WaPo our fears are confirmed–vaccine has been leaking out of this plant despite the fact that the plant was never authorized by FDA. Still wondering if this was related to some of those clinic shut-downs?The storyline is that the unapproved vaccine went to Canada and Mexico. Are you relieved yet? From the WaPo:…
A common cold literature review mentions the RSV vaccine trial, Vit C, Echinacea and zinc
From a 2004 review of the common cold. This paper says 10-15% of colds are due to coronaviruses. Some suggest a higher percentage. It can be useful to read literature that is untainted by current political considerations. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125703/ The development of an RSV vaccine has been hampered by the experience with formalin-inactivated whole RSV vaccine…
Common Sense Approaches to Improving Ebola Survival/ The Lancet
I have been talking about how one might improve clinical care of Ebola patients, and the need for trials to identify the best treatments, best empiric iv fluids, etc. This is necessary both to improve survival rates and also to give Ebola patients a reason to come to Ebola treatment centers, which many perceive to be…